MECFC 2019
3rd Annual Middle East
Cystic Fibrosis Conference
Istanbul, Turkey
March 21st, 22nd and 23rd
March 21
MECFA- Road to the Future - Christine Noke, MECFA CEO, USA
European Standards of Care - How did we make and maintain them? - Carlo Castellani, ITA
Survey of CF Care in the Middle East - Results - Hussein Al Kindi, OMN
Developing CF Centers in the region - The MaMi Project - Samya Nasr, USA
Combating cross contamination in clinical care - the rules of hygiene - Bulent Karadag, TUR
Recent Advances in CF CRMS/CFSPID - Carlo Castellani, ITA
Update on ongoing studies in CF - Samya Nasr, USA
Lobbying for CF care in the Middle East - Ibrahim Al Janahi, QAT
Lobbying for CF Care in the Middle East - İlknur Özgür Görgün - President of KIFDER, TUR
CF Genetics in the Middle East - Hussein Al Kindi, OMN
CF Genetics in the Middle East - Atqah Abdulwahab, QAT
March 22
Therapeutic drug monitoring and pharmacokinetics in CF - Daniel Touw, NLD
The important role of patient organizations: CF Europe - Jacquelien Noordhoek, NLD
Update on new drugs for CF and the Rainbow Project - Hendrikus Heijerman, NLD
CF In the Middle East - CF Iran -Mohammedreza Modaresi, IRN
CF In the Middle East - CF Egypt-Nader Fasseeh, EGY
CF In the Middle East - CF in Omani and Pakistan/Indian Patients - Hussein Al Kindi, OMN
Home-made therapies for CF; a recipe for lower cost treatments - Daniel Touw, NLD
CF-IDEA, A non-profit solution to high cost therapies - Christine Noke, USA
Physiotherapy in CF-US and Middle East Experience - Christopher Tapley, USA
Physiotherapy in CF-US and Middle East Experience - Özge Keniş, TUR
Honorary International Speakers
Netherlands
USA
Czech Republic
Italy
Germany
USA
Netherlands
USA
USA
Netherlands
USA
Honorary Regional Speakers
Turkey
Palestine
Qatar
Oman
Turkey
Turkey
Turkey
Turkey
Egypt
Jordan
Turkey
Turkey
Iran
Qatar
Qatar
Conference Committee
Turkey
Palestine
USA
Netherlands